12-month efficacy data from Phase 2 study of CYB003 in MDD expected in early Q4 2024 - - Phase 2 topline efficacy and safety results for CYB004 in Generalized Anxiety Disorder (“GAD”) expected ...

Most of us have faced anxiety at one time or another. A recent viral Reddit thread, proving we’re not alone, asked, 'How do ...

A sense of impending doom is a sudden, overwhelming feeling that something bad is going to happen even though there's no ...

Paxil (paroxetine) and Lexapro (escitalopram) are both part of the SSRI medication class. While they share many similarities, ...

People with generalized anxiety disorder (GAD), however, often feel excessive feelings of worry, dread, and fear regardless of the circumstances. This means people with GAD feel high levels of anxiety ...

Anxiety in seniors is a serious mental health condition that can have a significant impact on their quality of life.

Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder ... professional of GAD in the past 12 months ...

Anxiety is a common mental health concern that affects millions of people worldwide. Whether it's triggered by work-related stress, personal life challenges.

A model with a mixture of three different decision strategies is developed to characterize several atypical behavioral patterns of individuals with depression and anxiety in an uncertain reward ...

A certain amount of anxiety as we go about our daily lives is normal. Most adults can navigate their way through the nagging concerns that dog their thoughts without getting derailed by them. Children ...

Cybin CEO Doug Drysdale talks to Jason Najum about treating mental health disorders with psychedelics and attracting new buyers with its stock price.